ES2103737T3 - Preparacion de aerosol para uso externo. - Google Patents

Preparacion de aerosol para uso externo.

Info

Publication number
ES2103737T3
ES2103737T3 ES90904670T ES90904670T ES2103737T3 ES 2103737 T3 ES2103737 T3 ES 2103737T3 ES 90904670 T ES90904670 T ES 90904670T ES 90904670 T ES90904670 T ES 90904670T ES 2103737 T3 ES2103737 T3 ES 2103737T3
Authority
ES
Spain
Prior art keywords
aerosol
preparation
external use
sprayed
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90904670T
Other languages
English (en)
Inventor
Toshimitu Seki
Kingo Narumi
Tatuoki Iguchi
Shouzou Kouchiwa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13238881&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2103737(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2103737T3 publication Critical patent/ES2103737T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/01—Aerosol hair preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Materials For Photolithography (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Gyroscopes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION PROVEE UNA NUEVA PREPARACION DE AEROSOL PARA USO EXTERNO, DIRIGIDO PRINCIPALMENTE AL ENFRIAMIENTO DE LA PIEL, EL CUAL FORMA ESPUMA DE TIPO GRANIZADO CUANDO SE PULVERIZA. LA SOLUCION ALMACENADA ESTA COMPUESTA DE UNA MEZCLA DE AGUA CON UN ALCOHOL INFERIOR COMO BASE Y UNA MEZCLA DE GAS DE PETROLEO LICUADO CON DIMETILO ETER COMO PROPELENTE, MEZCLADO EN UNA PROPORCION DE COMPOSICION ESPECIFICA DE MODO QUE FORMA ESPUMAS DE TIPO GRANIZADO. ESTA PREPARACION DE AEROSOL ESTA PREPARADA PARA EXHIBIR UN EFECTO COMBINADO DE LA PREPARACION DEL AEROSOL COMO REFRIGERANTE Y COMO LA DROGA INGREDIENTE PRINCIPAL. ES ESPECIALMENTE EXCELENTE EN SU APLICACION A LA PARTE AFECTADA DE UN CUERPO HUMANO EN COMPARACION CON LAS PREPARACIONES DE AEROSOL DE USO EXTERNO, LAS CUALES SE PULVERIZAN EN FORMA DE GOTITAS.
ES90904670T 1989-03-17 1990-03-16 Preparacion de aerosol para uso externo. Expired - Lifetime ES2103737T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6376889 1989-03-17

Publications (1)

Publication Number Publication Date
ES2103737T3 true ES2103737T3 (es) 1997-10-01

Family

ID=13238881

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90904670T Expired - Lifetime ES2103737T3 (es) 1989-03-17 1990-03-16 Preparacion de aerosol para uso externo.

Country Status (10)

Country Link
US (1) US5397564A (es)
EP (1) EP0414920B2 (es)
JP (1) JP2903708B2 (es)
KR (1) KR0137784B1 (es)
AT (1) ATE152908T1 (es)
CA (1) CA2028811C (es)
DE (1) DE69030698T2 (es)
DK (1) DK0414920T3 (es)
ES (1) ES2103737T3 (es)
WO (1) WO1990011068A1 (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2273299A (en) * 1992-12-08 1994-06-15 Nelly Kamel Rizk Mixture that produces cooling
EP0713386B1 (en) * 1993-08-10 1998-11-18 The Boots Company PLC Spray formulation having a cooling effect
AU705038B2 (en) * 1995-12-14 1999-05-13 Taisho Pharmaceutical Co., Ltd. Aerosol preparation
WO1998056350A1 (en) * 1997-06-13 1998-12-17 Taisho Pharmaceutical Co., Ltd. Aerosols
CN1092515C (zh) * 1997-08-07 2002-10-16 大正制药株式会社 粉末气雾剂
US6214318B1 (en) * 1997-10-02 2001-04-10 Oms Holdings Llc Aerosol ointment compositions for topical use
AUPO983897A0 (en) 1997-10-17 1997-11-06 Soltec Research Pty Ltd Topical antifungal composition
US6187695B1 (en) 1998-12-08 2001-02-13 Kimberly-Clark Worldwide, Inc. Cool feeling tissue product and method
US6235265B1 (en) * 1998-10-28 2001-05-22 Alliedsignal Inc. Evaporative coolant for topical anesthesia comprising hydrofluorocarbons and/or hydrochlorofluorocarbons
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US20060140984A1 (en) 2002-10-25 2006-06-29 Foamix Ltd. Cosmetic and pharmaceutical foam
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
WO2004064833A1 (en) * 2003-01-24 2004-08-05 Connetics Australia Pty Ltd. Clindamycin phosphate foam
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US7186416B2 (en) * 2003-05-28 2007-03-06 Stiefel Laboratories, Inc. Foamable pharmaceutical compositions and methods for treating a disorder
JP4615198B2 (ja) * 2003-07-25 2011-01-19 久光製薬株式会社 抗真菌エアゾール外用製剤
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
EP1699431B1 (en) 2003-12-12 2015-08-19 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
US8940321B2 (en) 2003-12-12 2015-01-27 Otic Pharma Ltd. Compositions for treatment of ear disorders and methods of use thereof
CA2564822A1 (en) * 2004-04-30 2005-11-17 Burrell E. Clawson Apparatus and methods for isolating human body areas for localized cooling
JP5044103B2 (ja) * 2005-03-23 2012-10-10 株式会社ダイゾー 乳化型エアゾール組成物
US20100154146A1 (en) 2008-07-02 2010-06-24 S.C. Johnson & Son, Inc. Carpet decor and setting solution compositions
US8846154B2 (en) 2005-06-07 2014-09-30 S.C. Johnson & Son, Inc. Carpet décor and setting solution compositions
BRPI0709674A2 (pt) 2006-03-31 2011-12-06 Stiefel Research Australia Pty Ltd. gel de suspensão espumante
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2010041141A2 (en) 2008-10-07 2010-04-15 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US20090157153A1 (en) * 2007-12-13 2009-06-18 Sarah Anne Lemke Skin cooling system
CA2711703A1 (en) * 2008-01-08 2009-07-16 Foamix Ltd. Sensation modifying topical composition foam
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
JP5283389B2 (ja) * 2008-01-22 2013-09-04 株式会社ダイゾー エアゾール組成物
JP5507818B2 (ja) * 2008-04-14 2014-05-28 株式会社ダイゾー エアゾール組成物
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
US8058203B2 (en) * 2009-04-29 2011-11-15 Chevron U.S.A. Inc. Hydroconversion multi-metallic catalyst and method for making thereof
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
AU2010302350B2 (en) 2009-10-02 2015-06-18 Journey Medical Corporation Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US12661407B2 (en) 2010-04-08 2026-06-23 Journey Medical Corporation Compositions, gels and foams with rheology modulators and uses thereof
EP2614815B1 (en) * 2010-09-10 2019-01-16 Daizo Corporation Foamable aerosol composition
JP5970244B2 (ja) * 2011-06-03 2016-08-17 株式会社ダイゾー エアゾール組成物およびエアゾール製品
WO2013065051A1 (en) 2011-11-01 2013-05-10 Naveh Pharma (1996) Ltd. Formulation and device for treating ceruminosis
MX2020012139A (es) 2016-09-08 2021-01-29 Vyne Pharmaceuticals Inc Composiciones y metodos para tratar rosacea y acne.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1200259A (en) * 1967-10-09 1970-07-29 Precision Valve Corp Quick breaking foam hair preparation
US3705855A (en) * 1970-07-24 1972-12-12 Colgate Palmolive Co Reversible-emulsion aerosol system
JPS5432185A (en) * 1977-08-16 1979-03-09 Osaka Eyazooru Kougiyou Kk Method of manufacturing nonnfoaming and sprayable waterrcontaining aerosol products
JPS5486606A (en) * 1977-12-22 1979-07-10 Daikin Ind Ltd Aerosol composition for cooling
JPS56135414A (en) * 1980-03-27 1981-10-22 Hisamitsu Pharmaceut Co Inc Aerosol type antiphlogistic and analgesic
US4536323A (en) * 1983-06-28 1985-08-20 The Drackett Company Non-flammable aerosol propellant microemulsion system
US4534958A (en) * 1983-07-13 1985-08-13 Basf Wyandotte Corporation Aerosol gel
US4548807A (en) 1983-08-03 1985-10-22 Geoffrey J. Westfall Mastitis prevention
JPS6254784A (ja) * 1985-09-04 1987-03-10 Osaka Eyazoole Kogyo Kk エアゾ−ル組成物
JPS63108091A (ja) * 1986-10-24 1988-05-12 Lion Corp エアゾ−ル組成物
JPH0778019B2 (ja) * 1986-11-08 1995-08-23 久光製薬株式会社 泡状エアゾ−ル消炎鎮痛製剤
EP0376104B2 (en) * 1988-12-27 2003-08-20 Osaka Shipbuilding Co., Ltd. Aerosol composition
JP2759330B2 (ja) * 1988-12-28 1998-05-28 株式会社いすゞセラミックス研究所 電磁力バルブ駆動装置
JP2741105B2 (ja) * 1989-07-28 1998-04-15 久光製薬株式会社 泡状エアゾール製剤

Also Published As

Publication number Publication date
US5397564A (en) 1995-03-14
EP0414920A4 (en) 1991-08-07
EP0414920B1 (en) 1997-05-14
DE69030698T2 (de) 1997-10-02
WO1990011068A1 (en) 1990-10-04
KR0137784B1 (ko) 1998-05-15
EP0414920A1 (en) 1991-03-06
EP0414920B2 (en) 2006-09-27
KR920700025A (ko) 1992-02-19
CA2028811A1 (en) 1990-09-18
ATE152908T1 (de) 1997-05-15
DK0414920T3 (da) 1997-12-15
DE69030698D1 (de) 1997-06-19
JP2903708B2 (ja) 1999-06-14
CA2028811C (en) 1998-12-29

Similar Documents

Publication Publication Date Title
KR920700025A (ko) 외용 에어로졸제
MX2007010893A (es) Composiciones espumantes de alto contenido de alcohol con agentes tensioactivos basados en silicon.
BRPI0414883A (pt) composição, concentrado de composição, e, composições alcoólicas desinfetante e semelhante a gel
AR013614A1 (es) Nueva composicion que comprende una combinacion de esteroides, un kit que la contiene, el uso de la misma, el uso de dicho kit de formoterol y debudesonida en la fabricacion de un medicamento
KR920703011A (ko) 거품상 에어로솔제제
ES2046303T3 (es) Composicion para el cuidado de la piel.
ES2165122T3 (es) Nuevos derivados de amidina, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4.
UY34901A (es) ?monohidrato cristalino, procedimiento para su preparacion ysu utilizacion para la preparacion de un medicamento?.
ES2106029T3 (es) Composiciones que mejoran la penetracion a traves de la piel.
SV2009003288A (es) Derivados de 2, 3-dihidroimidazo [1,2-c] quinazolina sustituidos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogenesis
GT200300294A (es) Compuestos de indazol y composiciones farmaceuticas para inhibir proteinquinasas y procedimientos para su uso
ES2184131T3 (es) Derivados de benzamidina y su utilizacion como medicamentos con efecto antagonista de ltb4.
UY37149A (es) 2–amino–n–[7–metoxi–2,3–dihidroimidazo–[1,2–c]quinazolin–5–il]pirimidin–5–carboxamidas
ES2178048T3 (es) Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
WO2009087578A3 (en) Sensation modifying topical composition foam
ES2069100T3 (es) Inmunosupresor y procedimiento para la produccion del mismo.
ATE86850T1 (de) Schaumerzeugende rasierzusammensetzungen.
ES2173485T3 (es) Anestesico local para uso externo.
AR040130A1 (es) Esteres de etonogestrel, su uso como anticopceptivo y para el tratamiento de desordenes ginecologicos
AR060072A1 (es) Aerosoles dosificadores para la administracion de preparaciones farmaceuticas
ES2153412T3 (es) Agente externo para la piel.
ES2147453T3 (es) Antagonistas de adenosina, procedimiento para su preparacion y su uso como medicamentos.
SV1998000040A (es) Composiciones farmaceuticas ref. pu3210/sv
AR011807A1 (es) Una composicion antitranspirante en aerosol sustancialmente anhidra para la aplicacion topica sobre la piel humana, y uso no terapeutico de dicha composicion.
MX2024010528A (es) Composiciones que comprenden una mezcla de ingredientes activos que comprende silicio y biotina y metodos de uso

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 414920

Country of ref document: ES